Akaso Bio

About:

Akaso Bio focuses on the R&D and production of high-end microsphere products.

Top Investors: Delian Capital, Oasis Capital

Description:

Akaso Bio is a leader in 3D microfluidic chip technology, dedicated to exploring and expanding new applications of high-throughput microfluidic technology, and becoming an innovative solution provider for high-performance microsphere products.

Total Funding Amount:

20M CNY

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2021-01-01

Contact Email:

info(AT)akso-biotech.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-04-02

IPO Status:

Private

Industries: